当代医学
噹代醫學
당대의학
CHINA CONTEMPORARY MEDICINE
2015年
3期
142-143
,共2页
许仕超%张华丽%黎伟文%陈晓铭%武革
許仕超%張華麗%黎偉文%陳曉銘%武革
허사초%장화려%려위문%진효명%무혁
西格列汀%二甲双胍%2型糖尿病%疗效观察
西格列汀%二甲雙胍%2型糖尿病%療效觀察
서격렬정%이갑쌍고%2형당뇨병%료효관찰
Sitagliptin%Melbine%Type 2 diabetes%Efficacyobservation
目的:探讨西格列汀联合二甲双胍治疗2型糖尿病的临床疗效。方法随机选取2型糖尿病患者46例,随机均分为对照组与观察组(n=23),观察组患者采取西格列汀联合二甲双胍进行治疗,对照组采取吡格列酮联合二甲双胍进行治疗,对比2组患者治疗前后FBG、2 hPG、HbA 1c、BMI等指标的变化情况,以及是否出现不良反应。结果治疗后2组患者的FBG、2hPG、HbA1c、BMI等指标均有一定程度降低,尤其是FBG、2hPG下降较为显著,观察组FBG、2 hPG降低程度显著高于对照组(P<0.05);对照组出现胃肠道反应的患者为8例(34.78%),显著多于观察组的2例(8.70%),2组比较差异具有统计学意义(P<0.05)。结论对2型糖尿病患者采取西格列汀联合二甲双胍治疗,是一种有效安全的治疗方法,应在临床治疗过程中广泛使用。
目的:探討西格列汀聯閤二甲雙胍治療2型糖尿病的臨床療效。方法隨機選取2型糖尿病患者46例,隨機均分為對照組與觀察組(n=23),觀察組患者採取西格列汀聯閤二甲雙胍進行治療,對照組採取吡格列酮聯閤二甲雙胍進行治療,對比2組患者治療前後FBG、2 hPG、HbA 1c、BMI等指標的變化情況,以及是否齣現不良反應。結果治療後2組患者的FBG、2hPG、HbA1c、BMI等指標均有一定程度降低,尤其是FBG、2hPG下降較為顯著,觀察組FBG、2 hPG降低程度顯著高于對照組(P<0.05);對照組齣現胃腸道反應的患者為8例(34.78%),顯著多于觀察組的2例(8.70%),2組比較差異具有統計學意義(P<0.05)。結論對2型糖尿病患者採取西格列汀聯閤二甲雙胍治療,是一種有效安全的治療方法,應在臨床治療過程中廣汎使用。
목적:탐토서격렬정연합이갑쌍고치료2형당뇨병적림상료효。방법수궤선취2형당뇨병환자46례,수궤균분위대조조여관찰조(n=23),관찰조환자채취서격렬정연합이갑쌍고진행치료,대조조채취필격렬동연합이갑쌍고진행치료,대비2조환자치료전후FBG、2 hPG、HbA 1c、BMI등지표적변화정황,이급시부출현불량반응。결과치료후2조환자적FBG、2hPG、HbA1c、BMI등지표균유일정정도강저,우기시FBG、2hPG하강교위현저,관찰조FBG、2 hPG강저정도현저고우대조조(P<0.05);대조조출현위장도반응적환자위8례(34.78%),현저다우관찰조적2례(8.70%),2조비교차이구유통계학의의(P<0.05)。결론대2형당뇨병환자채취서격렬정연합이갑쌍고치료,시일충유효안전적치료방법,응재림상치료과정중엄범사용。
Objective To evaluate the clinical efficacy of sitagliptin with metformin in treatment of type 2 diabetes.Methods 46 patients with type 2 diabetes were selected as the study objects,then divided them into control group and observation group randomly(n=23). Sitagliptin combined with metformin was adopted in observation group, and pioglitazone combined with metformin was adopted in control group. Adverse reactions incidence, changes of indexes such as FBG,2hPG,HbA1c,BMI of two groups before and after treatment were compared.Results After treatment, the FBG,2hPG,HbA1c,BMI of two groups had decreased at a certain degree, especially FBG,2hPG was significant, and the decrease degree of FBG,2hPG in observation group was significantly higher than control group(P<0.05). Incidence of gastrointestinal reaction in control group were 8 cases (34.78%),and was significantly more than 2 cases of observation group (8.70%),the differences between two groups were statistically significant (P<0.05).Conclusion For the treatment of type 2 diabetes, sitagliptin combined with melbine is a effective treatment,which should be widely applied in clinic.